{
    "eid": "2-s2.0-84960192232",
    "title": "The many neuroprogressive actions of tryptophan catabolites (TRYCATs) that may be associated with the pathophysiology of neuro-immune disorders",
    "cover-date": "2016-03-01",
    "subject-areas": [
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Drug Discovery",
            "@code": "3002"
        }
    ],
    "keywords": [
        "Chronic fatigue",
        "Immune",
        "Inflammation",
        "Leaky gut",
        "Oxidative and nitrosative stress",
        "Schizophrenia"
    ],
    "authors": [
        "Gerwyn Morris"
    ],
    "citedby-count": 50,
    "ref-count": 283,
    "ref-list": [
        "Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseases.",
        "Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan - Kynurenine metabolism",
        "Redox regulation and the autistic spectrum: Role of tryptophan catabolites, immuno-inflammation, autoimmunity and the amygdala",
        "Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation",
        "The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression",
        "Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome",
        "The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): Relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation",
        "Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder",
        "Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder",
        "Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway",
        "Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways",
        "Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: A possible link between chronic inflammation and uraemic symptoms",
        "Obesity-related dysregulation of the Tryptophan-Kynurenine metabolism: Role of age and parameters of the metabolic syndrome",
        "Hepat Res Treat",
        "Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes",
        "Kynurenines, Parkinson's disease and other neurodegenerative disorders: Preclinical and clinical studies",
        "Kynurenine and its metabolites in nervous system diseases",
        "Huntington's disease, behavioral disturbances, and kynurenines: Preclinical findings and therapeutic perspectives",
        "Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease",
        "Neuroprotection in parkinson's disease and other neurodegenerative disorders: Preclinical and clinical findings",
        "Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection",
        "Kynurenine metabolism in multiple sclerosis",
        "Kynurenines, redox disturbances and neurodegeneration in multiple sclerosis",
        "Serum indoleamine 2,3-dioxygenase and kynurenine aminotransferase enzyme activity in patients with ischemic stroke",
        "Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity",
        "Kynurenine pathway in psychosis: Evidence of increased tryptophan degradation",
        "Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response",
        "Increased depressive ratings in patients with hepatitis C receiving interferon-\u03b1-based immunotherapy are related to interferon-\u03b1-induced changes in the serotonergic system",
        "Tryptophan degradation and immune activation in Alzheimer's disease",
        "Kynurenine metabolism in Alzheimer's disease",
        "Mol Neurobiol",
        "Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses",
        "Kynurenine pathway metabolites in humans: Disease and healthy states",
        "Shifting the balance of brain tryptophan metabolism elicited by isolation housing and systemic administration of lipopolysaccharide in mice",
        "Increased nuclear factor-\u03baB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS)",
        "Induction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential",
        "Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection",
        "Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: Implications for the control of alloresponses",
        "Epstein-barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and Nf-\u03baB pathways: Impairment in T cell functions",
        "Persistent infectious diseases say-IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy",
        "Essential role of excessive tryptophan and its neurometabolites in fatigue.",
        "Tryptophan and Kynurenic Acid May Produce an Amplified Effect in Central Fatigue Induced by Chronic Sleep Disorder",
        "Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue",
        "The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders",
        "Microglia and neurodegeneration: The role of systemic inflammation",
        "The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease: An emerging field",
        "Manipulation of brain kynurenines: Glial targets, neuronal effects, and clinical opportunities",
        "Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation",
        "Kynurenine pathway metabolism in human astrocytes: A paradox for neuronal protection",
        "Quinolinic acid production by macrophages stimulated with IFN-\u03b3, TNF- \u03b1, and IFN-\u03b1",
        "Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: A role for IFN-\u03b3?",
        "Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model",
        "LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-\u03b3-independent manner by a JNK signaling pathway in primary murine microglia",
        "CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: Additional mechanisms of T-cell inhibition",
        "LPS-induced NF-\u03baB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase",
        "Hemoglobin induces the expression of indoleamine 2,3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF-\u03baB and the generation of reactive oxygen species",
        "Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway",
        "Targeting key dioxygenases in tryptophan-kynurenine metabolism for immunomodulation and cancer chemotherapy",
        "The role of placental tryptophan catabolism",
        "Tryptophan catabolism in cancer: Beyond IDO and tryptophan depletion",
        "Kynurenines in the mammalian brain: When physiology meets pathology",
        "Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain",
        "Biochemical mechanisms leading to tryptophan 2,3-dioxygenase activation",
        "Implication of tryptophan 2,3-dioxygenase and its novel variants in the hippocampus and cerebellum during the developing and adult brain",
        "Kynurenines in CNS disease: Regulation by inflammatory cytokines",
        "Kynurenines with neuroactive and redox properties: Relevance to aging and brain diseases",
        "SYNTHESIS AND METABOLISM OF l\u2010KYNURENINE IN RAT BRAIN",
        "Kynurenines impair energy metabolism in rat cerebral cortex",
        "Copper-ligand interactions and physiological free radical processes. Part 3. Influence of histidine, salicylic acid and anthranilic acid on copper-driven Fenton chemistry in vitro",
        "Copper(II) interactions with nonsteroidal antiinflammatory agents. II. Anthranilic acid as a potential OH-inactivating ligand",
        "The preferred route of kynurenine metabolism in the rat",
        "Structural basis of kynurenine 3-monooxygenase inhibition",
        "Cortical kynurenine pathway metabolism: A novel target for cognitive enhancement in schizophrenia",
        "Formation of hydroxanthommatin-derived radical in the oxidation of 3-hydroxykynurenine",
        "Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine",
        "Characterisation of the major autoxidation products of 3- hydroxykynurenine under physiological conditions",
        "Experimental convulsions in rats induced by intra ventricular administration of kynurenine and structurally related compounds",
        "3-hydroxykynurenine toxicity on the rat striatum in vivo",
        "Tryptophan-derived ultraviolet filter compounds covalently bound to lens proteins are photosensitizers of oxidative damage",
        "In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Londrina",
            "affilname": "Universidade Estadual de Londrina",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Fortaleza",
            "affilname": "Universidade Federal do Cear\u00e1",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Geelong",
            "affilname": "Deakin University",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Lodz",
            "affilname": "University of Lodz",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "London",
            "affilname": "CRC Scotland &amp; London",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Llanelli",
            "affilname": "Tir Na Nog",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": []
}